Showing results (171-180 of 299) with videos related to

Sort By:
Pageof 30
Cancer Chemotherapy and Pharmacology|December 17, 2009
A phase I trial of PR-104, a nitrogen mustard prodrug activated by both hypoxia and aldo-keto reductase 1C3, in patients with solid tumorsMichael B Jameson, Danny Rischin, Mark Pegram, et al.
BMC Cancer|October 11, 2011
A phase I trial of PR-104, a pre-prodrug of the bioreductive prodrug PR-104A, given weekly to solid tumour patientsMark J McKeage, Yongchuan Gu, William R Wilson, et al.
World Journal of Clinical Oncology|October 16, 2015
Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neckMichael Mix, Anurag K Singh, Michael Tills, et al.
Chemical Science|September 9, 2024
Inverted strand polarity yields thermodynamically stable G-quadruplexes and prevents duplex formation within extended DNABruce Chilton, Ruby J Roach, Patrick J B Edwards, et al.
Insect Science|November 9, 2023
An electropenetrography waveform library for the probing and ingestion behaviors of Culex tarsalis on human handsAnastasia M W Cooper, Samuel B Jameson, Victoria Pickens, et al.
Biochemistry|October 27, 2022
Design, Synthesis, and Evaluation of a Cross-Linked Oligonucleotide as the First Nanomolar Inhibitor of APOBEC3AHarikrishnan M Kurup, Maksim V Kvach, Stefan Harjes, et al.
Pageof 30